International variation in female breast cancer incidence and mortality rates, Cancer Epidemiol Biomark Prev, vol.24, pp.1495-1506, 2015. ,
Two decades after BRCA: setting paradigms in personalized cancer care and prevention, Science, vol.343, pp.1466-1470, 2014. ,
Refining breast cancer risk stratification: additional genes, additional information, Am Soc Clin Oncol Educ Book, vol.35, pp.44-56, 2016. ,
Testing for hereditary breast cancer: panel or targeted testing? Experience from a clinical cancer genetics practice, J Genet Couns, vol.24, pp.683-687, 2014. ,
Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management, Front Oncol, vol.5, p.208, 2015. ,
Clinical evaluation of a multiplegene sequencing panel for hereditary cancer risk assessment, J Clin Oncol, vol.32, pp.2001-2009, 2014. ,
Gene-panel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-2257, 2015. ,
, Devilee P Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES), 2020.
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics, J Med Genet, vol.45, pp.425-431, 2008. ,
Clinical software development for the Web: lessons learned from the BOADI-CEA project, BMC Med Inform Decis Mak, vol.12, p.30, 2012. ,
Prospective validation of the breast cancer risk prediction model BOADI-CEA and a batch-mode version BOADICEACentre, Br J Cancer, vol.109, pp.1296-1301, 2013. ,
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, Br J Cancer, vol.110, pp.535-545, 2014. ,
Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model, Genet Med, vol.18, pp.1190-1198, 2016. ,
Barriers and facilitators to patient-provider communication when discussing breast cancer risk to aid in the development of decision support tools, AMIA Annu Symp Proc, pp.1352-1360, 2015. ,
Implementing a QCancer risk tool into general practice consultations: an exploratory study using simulated consultations with Australian general practitioners, Br J Cancer, vol.112, issue.1, pp.77-83, 2015. ,
Medical genetic counseling for breast cancer in primary care: a synthesis of major determinants of physicians' practices in primary care settings, Public Health Genom, vol.17, pp.190-208, 2014. ,
Exploratory multivariate analysis by example using R, Jolliffe IT. Principal component analysis, 2002. ,
URL : https://hal.archives-ouvertes.fr/hal-00566638
Breast cancer specialists' views on and use of risk prediction models in clinical practice: a mixed methods approach, Acta Oncol, vol.54, pp.361-367, 2015. ,
Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers, Fam Cancer, vol.12, pp.65-73, 2013. ,
Methods to increase response to postal and electronic questionnaires, Cochrane Database Syst, 2009. ,
Maximising response from GPs to questionnaire surveys: do length or incentives make a difference, BMC Med Res Methodol, vol.15, p.3, 2015. ,
LimeSurvey: an open source survey tool, 2015. ,
Using multivariate statistics, 6th edn, 2013. ,
R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2016. ,
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2, Am J Hum Genet, vol.62, pp.145-158, 1998. ,
Recent enhancements to the genetic risk prediction model BRCAPRO, Cancer Inform, vol.14, pp.147-157, 2015. ,
A breast cancer prediction model incorporating familial and personal risk factors, Stat Med, vol.23, pp.1111-1130, 2004. ,
iPrevent(R): a tailored, web-based, decision support tool for breast cancer risk assessment and management, Breast Cancer Res Treat, vol.156, pp.171-182, 2016. ,
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the german hereditary breast and ovarian cancer consortium, J Med Genet, vol.50, pp.360-367, 2014. ,
Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk, J Natl Cancer Inst, vol.107, p.124, 2015. ,
General practitioners and breast surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles, BMC Cancer, vol.15, p.243, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01216078
Assessing women at high risk of breast cancer: a review of risk assessment models, J Natl Cancer Inst, vol.102, pp.680-691, 2010. ,
Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers, BMC Med Inform Decis Mak, vol.13, issue.2, p.7, 2013. ,
Online tool to guide decisions for BRCA1/2 mutation carriers, J Clin Oncol, vol.30, pp.497-506, 2012. ,
Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer, Fam Cancer, vol.15, pp.341-350, 2015. ,
A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital, Breast Cancer Res Treat, vol.159, pp.527-534, 2016. ,